0001192482-21-000264.txt : 20210322 0001192482-21-000264.hdr.sgml : 20210322 20210322151809 ACCESSION NUMBER: 0001192482-21-000264 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210322 DATE AS OF CHANGE: 20210322 EFFECTIVENESS DATE: 20210322 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Spine BioPharma, LLC CENTRAL INDEX KEY: 0001852647 IRS NUMBER: 831212524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-393044 FILM NUMBER: 21761151 BUSINESS ADDRESS: STREET 1: 505 PARK AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-583-9700 MAIL ADDRESS: STREET 1: 505 PARK AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001852647 Spine BioPharma, LLC 505 PARK AVENUE, 14TH FLOOR NEW YORK NY NEW YORK 10022 212-583-9700 DELAWARE None None Limited Liability Company true Marc R. Viscogliosi 505 Park Avenue, 14th floor New York NY NEW YORK 10022 Executive Officer Manager and Chief Executive Officer of the Issuer John J Viscogliosi 505 Park Avenue, 14th floor New York NY NEW YORK 10022 Executive Officer Manager of the Issuer LLC Viscogliosi Brothers, 505 Park Avenue, 14th floor New York NY NEW YORK 10022 Executive Officer Member of the Issuer Pharmaceuticals Decline to Disclose 06b false 2021-03-12 false true false 25000 5000515 5000515 0 The offering is of Class A Preferred Units false 14 0 0 0 false Spine BioPharma, LLC /s/ Marc R. Viscogliosi Marc R. Viscogliosi Manager and Chief Executive Officer of the Issuer 2021-03-22